Benzo[a]pyrene

CAT:
804-HY-107377-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Benzo[a]pyrene - image 1

Benzo[a]pyrene

  • Description:

    Benzo[a]pyrene shows lung carcinogenicity in animal models, and it is frequently used in chemoprevention studies.
  • Product Name Alternative:

    3,4-Benzopyrene
  • UNSPSC:

    12352005
  • Hazard Statement:

    H316, H317, H340, H350, H360, H400, H410
  • Target:

    Endogenous Metabolite
  • Type:

    Natural Products
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/Benzo-a-pyrene.html
  • Purity:

    99.97
  • Solubility:

    DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    C12=C(C=C3)C=C(C=CC=C4)C4=C1C=CC5=CC=CC3=C25
  • Molecular Formula:

    C20H12
  • Molecular Weight:

    252.31
  • Precautions:

    H316, H317, H340, H350, H360, H400, H410
  • References & Citations:

    [1]Saeko Onami, et al. Dosimetry for lung tumorigenesis induced by urethane, 4- (N-methyl-N-nitrosamino) -1- (3-pyridyl) -1-butanone (NNK), and benzo[a]pyrene (B[a]P) in A/JJmsSlc mice. J Toxicol Pathol. 2017 Jul; 30 (3) : 209–216.|[2]Yeo CD, et al. Roflumilast treatment inhibits lung carcinogenesis in benzo (a) pyrene-induced murine lung cancer model. Eur J Pharmacol. 2017 Oct 5;812:189-|[3]Foth H, et al. Pharmacokinetics of low doses of benzo [a] pyrene in the rat[J]. Food and chemical toxicology, 1988, 26 (1) : 45-51.|[4]Anandakumar P, et al. Capsaicin inhibits benzo (a) pyrene-induced lung carcinogenesis in an in vivo mouse model. Inflamm Res. 2012 Nov;61 (11) :1169-75.|[5]Kasala ER, et al. Benzo (a) pyrene induced lung cancer: Role of dietary phytochemicals in chemoprevention. Pharmacol Rep. 2015 Oct;67 (5) :996-1009.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    Store at room temperature 3 years
  • Scientific Category:

    Natural Products
  • Clinical Information:

    Phase 1
  • CAS Number:

    [50-32-8]